Market Cap 1.52B
Revenue (ttm) 2.80M
Net Income (ttm) -115.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,113.57%
Debt to Equity Ratio 0.00
Volume 2,951,400
Avg Vol 4,546,376
Day's Range N/A - N/A
Shares Out 171.61M
Stochastic %K 29%
Beta 2.42
Analysts Strong Sell
Price Target $13.89

Company Profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
Synergy_CPA
Synergy_CPA Sep. 1 at 7:02 PM
$ABSI who's here because of the article, "Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine" ??
0 · Reply
Bfunk17
Bfunk17 Sep. 1 at 3:17 PM
$ABSI Be in it to win it. Solid play with a big binary coming in the next 2 months. (I am thinking October).
1 · Reply
Stock_Wizards
Stock_Wizards Sep. 1 at 12:46 PM
$RTB launches Roundtable100 and… what the 😂 $NVIDIA #6 while $ABSI is #1?? These rankings are gonna be VERY interesting. 👀 https://roundtable100.com/
0 · Reply
flam70
flam70 Sep. 1 at 12:32 AM
$ABSI Hair-Loss Drug Stocks Soar as Wall Street’s Next Big Bet After GLP-1 Boom - Bloomberg https://share.google/olKxTRd6S5xevmTNW
0 · Reply
teaman60
teaman60 Aug. 31 at 11:22 PM
$ABSI has strength
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Aug. 31 at 10:36 PM
$ABSI IM PAYTIENT!!!💪🏾🍷
0 · Reply
musky54
musky54 Aug. 31 at 8:10 PM
$ABSI anyone know if the volume at the end of the day was buying or selling
1 · Reply
G101SPM
G101SPM Aug. 28 at 6:08 PM
$ABSI $8.69 bid. SELL/TAKE PROFIT ON 25% OF NET LONG POSITION TO REDUCE ORIGINAL INVESTMENT COST TO ZERO. https://stocktwits.com/search/u/G101SPM?symbol=ABSI
0 · Reply
flam70
flam70 Aug. 28 at 4:27 AM
$ABSI https://www.marketbeat.com/instant-alerts/filing-artia-global-partners-lp-acquires-shares-of-464444-absci-corporation-absi-2026-08-27/
0 · Reply
MAs_Crxss
MAs_Crxss Aug. 27 at 5:47 PM
$ABSI @stockmongerer bash me for this play. I’m still holding, haven’t taken any profits… +312%
0 · Reply
Latest News on ABSI
Absci to Participate in Upcoming Investor Conferences

Sep 1, 2026, 8:00 AM EDT - 1 day ago

Absci to Participate in Upcoming Investor Conferences


Absci reports Q2 EPS (21c), consensus (20c)

2026-08-17T11:12:03.000Z - 16 days ago

Absci reports Q2 EPS (21c), consensus (20c)


Absci Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 22 days ago

Absci Earnings Call Transcript: Q2 2026


Absci Earnings release: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 22 days ago

Absci Earnings release: Q2 2026


Absci Quarterly report: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 22 days ago

Absci Quarterly report: Q2 2026


Absci Slides: Corporate presentation

Aug 11, 2026, 7:00 AM EDT - 22 days ago

Absci Slides: Corporate presentation


Absci management to meet virtually with KeyBanc

2026-07-21T19:20:11.000Z - 6 weeks ago

Absci management to meet virtually with KeyBanc


Absci director buys $149K in common stock

2026-07-07T00:00:10.000Z - 1 month ago

Absci director buys $149K in common stock


Absci price target raised to $10 from $4.10 at Morgan Stanley

2026-06-25T10:50:47.000Z - 2 months ago

Absci price target raised to $10 from $4.10 at Morgan Stanley


Absci price target raised to $16 from $8 at H.C. Wainwright

2026-06-25T10:06:19.000Z - 2 months ago

Absci price target raised to $16 from $8 at H.C. Wainwright


Absci prices 13.5M shares at $7.41 in public offering

2026-06-24T10:40:14.000Z - 2 months ago

Absci prices 13.5M shares at $7.41 in public offering


Absci reports Phase 1 data from human trial of ABS-201

2026-06-24T10:35:24.000Z - 2 months ago

Absci reports Phase 1 data from human trial of ABS-201


Absci price target raised to $15 from $10 at Guggenheim

2026-06-15T10:40:07.000Z - 2 months ago

Absci price target raised to $15 from $10 at Guggenheim


Absci Slides: FY 2026

Jun 9, 2026, 3:20 PM EDT - 2 months ago

Absci Slides: FY 2026


Absci Transcript: AGM 2026

Jun 4, 2026, 9:00 AM EDT - 3 months ago

Absci Transcript: AGM 2026


Absci initiated with an Outperform at Leerink

2026-06-04T10:38:54.000Z - 3 months ago

Absci initiated with an Outperform at Leerink


Absci Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 7:35 AM EDT - 3 months ago

Absci Transcript: Jefferies Global Healthcare Conference 2026


Absci Slides: FY 2026

Jun 3, 2026, 7:35 AM EDT - 3 months ago

Absci Slides: FY 2026


Absci initiated with a Buy at BTIG

2026-05-28T11:20:41.000Z - 3 months ago

Absci initiated with a Buy at BTIG


Absci price target raised to $11 from $9 at JonesResearch

2026-05-13T08:40:11.000Z - 3 months ago

Absci price target raised to $11 from $9 at JonesResearch


Absci reports Q1 EPS (19c), consensus (20c)

2026-05-07T22:23:30.000Z - 3 months ago

Absci reports Q1 EPS (19c), consensus (20c)


Absci Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Absci Earnings Call Transcript: Q1 2026


Absci Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Absci Earnings release: Q1 2026


Absci Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Absci Quarterly report: Q1 2026


Absci Slides: Corporate presentation

May 7, 2026, 4:00 PM EDT - 3 months ago

Absci Slides: Corporate presentation


Absci Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Absci Proxy statement: Proxy filing


Absci Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Absci Proxy statement: Proxy filing


Absci Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 5 months ago

Absci Earnings Call Transcript: Q4 2025


Absci Annual report: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 5 months ago

Absci Annual report: Q4 2025


Absci Earnings release: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 5 months ago

Absci Earnings release: Q4 2025


Absci reports Q4 EPS (20c), consensus (17c)

2026-03-24T20:13:40.000Z - 5 months ago

Absci reports Q4 EPS (20c), consensus (17c)


Absci Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 10:00 AM EDT - 5 months ago

Absci Transcript: Leerink Global Healthcare Conference 2026


Absci Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 9:10 AM EST - 6 months ago

Absci Transcript: TD Cowen 46th Annual Health Care Conference


Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference


Absci Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

Absci Slides: 44th Annual J.P. Morgan Healthcare Conference


Absci Transcript: Status Update

Dec 11, 2025, 10:00 AM EST - 8 months ago

Absci Transcript: Status Update


Absci Press release: Status Update

Dec 11, 2025, 10:00 AM EST - 8 months ago

Absci Press release: Status Update


Absci Slides: Status Update

Dec 11, 2025, 10:00 AM EST - 8 months ago

Absci Slides: Status Update


Absci Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 4:30 AM EST - 9 months ago

Absci Transcript: Jefferies London Healthcare Conference 2025


Absci Slides: FY 2025

Nov 18, 2025, 4:30 AM EST - 9 months ago

Absci Slides: FY 2025


Absci Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

Absci Earnings Call Transcript: Q3 2025


Absci Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

Absci Quarterly report: Q3 2025


Absci Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 9 months ago

Absci Earnings release: Q3 2025


Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 11 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD


Absci Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q2 2025


Absci Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Quarterly report: Q2 2025


Absci Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q2 2025


Absci Registration statement: Registration Filing

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Absci Registration statement: Registration Filing


Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 1 year ago

Absci Announces Pricing of Public Offering of Common Stock


Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 1 year ago

Absci Announces Proposed Public Offering of Common Stock


Absci Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q1 2025


Absci Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q1 2025


Absci Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Quarterly report: Q1 2025


Absci Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing


Absci Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing


Absci Registration statement: Registration Filing

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Absci Registration statement: Registration Filing


Absci Transcript: KeyBanc Annual Health Care Forum 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Transcript: KeyBanc Annual Health Care Forum 2025


Absci Slides: FY 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Slides: FY 2025


Absci Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q4 2024


Absci Annual report: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Annual report: Q4 2024


Absci Earnings release: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q4 2024


Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 3:10 PM EST - 1 year ago

Absci Transcript: TD Cowen 45th Annual Healthcare Conference


Absci Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 3:00 PM EST - 1 year ago

Absci Transcript: Guggenheim SMID Cap Biotech Conference


Absci Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Slides: FY 2025


Absci Transcript: R&D Day 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Transcript: R&D Day 2024


Absci Press release: FY 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Press release: FY 2024


Absci Slides: FY 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Slides: FY 2024


Absci Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 1:50 PM EST - 1 year ago

Absci Transcript: Stifel 2024 Healthcare Conference


Absci Transcript: UBS Global Healthcare Conference

Nov 13, 2024, 10:15 AM EST - 1 year ago

Absci Transcript: UBS Global Healthcare Conference


Absci Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings Call Transcript: Q3 2024


Absci Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Quarterly report: Q3 2024


Absci Earnings release: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings release: Q3 2024


Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024


Absci Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings Call Transcript: Q2 2024


Absci Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Quarterly report: Q2 2024


Absci Earnings release: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings release: Q2 2024


Absci Earnings Call Transcript: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings Call Transcript: Q1 2024


Absci Quarterly report: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Quarterly report: Q1 2024


Absci Earnings release: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings release: Q1 2024


Absci Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing


Absci Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing


Absci Annual report: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Annual report: Q4 2023


Absci Earnings release: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Earnings release: Q4 2023


Absci Transcript: KeyBanc’s Emerging Technology Summit

Mar 6, 2024, 12:00 PM EST - 2 years ago

Absci Transcript: KeyBanc’s Emerging Technology Summit


Absci Transcript: TD Cowen 44th Annual Health Care Conference

Mar 4, 2024, 2:10 PM EST - 2 years ago

Absci Transcript: TD Cowen 44th Annual Health Care Conference


Synergy_CPA
Synergy_CPA Sep. 1 at 7:02 PM
$ABSI who's here because of the article, "Forget GLP-1 stocks, baldness drugs are Wall Street’s next gold mine" ??
0 · Reply
Bfunk17
Bfunk17 Sep. 1 at 3:17 PM
$ABSI Be in it to win it. Solid play with a big binary coming in the next 2 months. (I am thinking October).
1 · Reply
Stock_Wizards
Stock_Wizards Sep. 1 at 12:46 PM
$RTB launches Roundtable100 and… what the 😂 $NVIDIA #6 while $ABSI is #1?? These rankings are gonna be VERY interesting. 👀 https://roundtable100.com/
0 · Reply
flam70
flam70 Sep. 1 at 12:32 AM
$ABSI Hair-Loss Drug Stocks Soar as Wall Street’s Next Big Bet After GLP-1 Boom - Bloomberg https://share.google/olKxTRd6S5xevmTNW
0 · Reply
teaman60
teaman60 Aug. 31 at 11:22 PM
$ABSI has strength
0 · Reply
WINNINGWEEZER
WINNINGWEEZER Aug. 31 at 10:36 PM
$ABSI IM PAYTIENT!!!💪🏾🍷
0 · Reply
musky54
musky54 Aug. 31 at 8:10 PM
$ABSI anyone know if the volume at the end of the day was buying or selling
1 · Reply
G101SPM
G101SPM Aug. 28 at 6:08 PM
$ABSI $8.69 bid. SELL/TAKE PROFIT ON 25% OF NET LONG POSITION TO REDUCE ORIGINAL INVESTMENT COST TO ZERO. https://stocktwits.com/search/u/G101SPM?symbol=ABSI
0 · Reply
flam70
flam70 Aug. 28 at 4:27 AM
$ABSI https://www.marketbeat.com/instant-alerts/filing-artia-global-partners-lp-acquires-shares-of-464444-absci-corporation-absi-2026-08-27/
0 · Reply
MAs_Crxss
MAs_Crxss Aug. 27 at 5:47 PM
$ABSI @stockmongerer bash me for this play. I’m still holding, haven’t taken any profits… +312%
0 · Reply
7m3835d3
7m3835d3 Aug. 27 at 4:24 PM
$ABSI nice volume spike at 12:03pm! 690k
2 · Reply
QuantInsider
QuantInsider Aug. 26 at 6:30 PM
$ABSI taking a hit, down about 3.9% today and 3.2% over the last five days after the lock-up expiration That’s putting some pressure on new longs with the supply overhang Noticed a chunky call block at 10:04 ET, three Jan 2028 $3 deep ITM calls, 2,247 contracts, around $1.53M premium, all on the ask No put flow, so someone’s betting on long delta exposure into this dip While it props up the bull case a bit, the deep ITM setup and ongoing selling pressure keep short-term plays tricky Feels like a long game here, not a quick win
1 · Reply
LivermoresGhost
LivermoresGhost Aug. 26 at 4:26 AM
$CVAT $CVAT BUYOUT ALERT: Cavitation Technologies CVAT has execute a buyout for this company at 35 million $. This translate to 11.2c per share, you can finds this on the company SEC filing. The stock right now trades 4.3c, the buyout is for 11.2c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 11.2c Current sp: 4.3c 270% Return on Investment, Tender will start this week!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! https://in.investing.com/news/stock-market-news/cavitation-technologies-agrees-to-35-million-acquisition-deal-93CH-5559884 Here is the company thats buying Cavitation, they have 20 billion Euros Capital Backing. https://euroguarantee.lu/ $ABSI $PESI $RAND $UPB
0 · Reply
MAs_Crxss
MAs_Crxss Aug. 25 at 9:08 PM
$ABSI @UpTick_ come here
0 · Reply
sogenerous
sogenerous Aug. 25 at 2:49 PM
$BEAM $PRME $ABCL $ABSI bios have been strong $XBI
1 · Reply
flam70
flam70 Aug. 25 at 12:45 PM
$ABSI https://www.marketbeat.com/instant-alerts/filing-parkman-healthcare-partners-llc-acquires-new-shares-in-absci-corporation-absi-2026-08-25/
1 · Reply
septrading
septrading Aug. 22 at 1:17 AM
$ABSI Getting ready to pull the trigger here. So the real ABSI bet is not simply PRLR blockade grows hair. Hope Medicine has already taken that proposition partway into the clinic. The differentiated ABSI bet is that continuous, high-level PRLR blockade for months will regenerate the follicular progenitor niche and produce substantially more terminal hair than the shorter-lived first-generation antibody. That is a coherent and potentially very valuable hypothesis. The upcoming controlled human data are the first real test of it. While HopeMed completed its randomized 24-week study in 2024, ABSI may get its controlled results out first. Absci’s 13-week readout is likely to be the next publicly disclosed PRLR hair-loss dataset. Absci has explicitly guided to an interim proof-of-concept disclosure in the second half of 2026 and full proof-of-concept data in early 2027. HopeMed has not announced any date for releasing its completed 2024 Phase 2 results. HopeMed is private and has no obligation to run a public-company catalyst calendar. It can keep the 2024 data confidential while speaking with regulators, investors, partners or Bayer. Absci is public, has just raised substantial capital, and has repeatedly positioned the 13-week dataset as its principal 2026 catalyst. It therefore has strong incentives to disclose promptly once the interim analysis is ready. What am I missing here?
2 · Reply
BobBijawklah
BobBijawklah Aug. 20 at 5:08 PM
0 · Reply
BobBijawklah
BobBijawklah Aug. 20 at 2:26 AM
$ABSI I could use some hair. Fudge hairclub for men.
0 · Reply
MAs_Crxss
MAs_Crxss Aug. 19 at 8:32 PM
$MRNA $OPEN $ABSI kaCHING what a day
1 · Reply
BobBijawklah
BobBijawklah Aug. 19 at 5:09 PM
$ABSI just so you all are aware the dosing of abs201 is two three subcutaneous injections in the scalp region over a 6 month period . No further doses. In the primate trial hair regrowth has increased and is sustained through year 4. So a true disease modifying cure for pattern baldness in both men and women.
0 · Reply
BobBijawklah
BobBijawklah Aug. 19 at 4:49 PM
$LLY Eli lilly has a 40 million dollar investmetn in ABSI . This is a 5-10 bagger as this appears to be the first drug that permantely regrows hair . It will start a bidding war and Lilly wants to have a say or strategic advantage in being the first to have the oppurtunity to aquire. In addition $AMD has invested 20 million in $ABSI . Get in now this one is going to blow when they release the phase 2 data it will be stellar as monkeys and humans share 99% DNA. They appear to have one of the best or first AI driven drug discovery platforms expect many more compounds and partnerships soon.
4 · Reply